Prazosin Hydrochloride NDC 70518-3271

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3271Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3271Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3271-0	70518327100	30 POUCH in 1 BOX (70518-3271-0) / 1 CAPSULE in 1 POUCH (70518-3271-1)Marketed from Nov 17, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prazosin Hydrochloride
Generic name (nonproprietary): prazosin hydrochloride
Active ingredients: Prazosin hydrochloride — 1 mg/1
Dosage form: Capsule
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 017442
Marketing start: Nov 17, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 70518-3271_58508dd2-8618-93c3-e063-6294a90aeccbSPL ID 58508dd2-8618-93c3-e063-6294a90aeccbSPL set ID 2f86fc8e-71c1-4749-b67e-86d86cf1d984RxCUI 312593UNII X0Z7454B90
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518327100 followed by a unit qualifier and the quantity

Package 70518-3271-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 5, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve b…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 017442

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 017442
Product	Strength	Form · route	Labeler	Product NDC
Prazosin Hydrochloride	Prazosin hydrochloride 5 mg/1	CapsuleOral	Prasco Laboratories	66993-433
Prazosin Hydrochloride	Prazosin hydrochloride 2 mg/1	CapsuleOral	Prasco Laboratories	66993-432
Prazosin Hydrochloride	Prazosin hydrochloride 1 mg/1	CapsuleOral	Prasco Laboratories	66993-431